Tamoxifen (Nolvadex) placebo

DRUG2 trials

Sponsors

AstraZeneca, Ente Ospedaliero Ospedali Galliera

Conditions

Breast CancerBreast Cancer Invasive

Phase 3

ATAC - Arimidex, Tamoxifen Alone or in Combination

CompletedNCT00849030

AstraZenecaBreast Cancer

Start: 1996-07-31End: 2010-04-30Updated: 2012-06-06

Unknown Phase

Long-term Follow-up of the TAM-01 Study and Pooled Analysis of Low-dose Tamoxifen Studies in Non-invasive or Microinvasive Breast Neoplasms

CompletedNCT06982313

Ente Ospedaliero Ospedali GallieraBreast Cancer Invasive

Start: 1996-07-01End: 2026-03-08Target: 1545Updated: 2026-03-11